Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 4Unknown 3Not yet recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 2Breast 2

Conditions

Leukemia, Myeloid, Acute 2Triple Negative Breast Neoplasms 1HER2-negative Breast Cancer 1Breast Neoplasms 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Anthracyclines × Clear all
NCT07548710 2026-06-03

Study of SA+X in the Treatment of Newly Diagnosed AML

Ruijin Hospital

Phase 2 Recruiting
205 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06802757 2026-02-25

PRISM-TNBC

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
72 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06451861 2025-11-17

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Guangdong Provincial People's Hospital

Phase 2 Recruiting
240 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06102824 2024-11-25

ORIENTA

Guangdong Provincial People's Hospital

Phase 2 Recruiting
252 enrolled
Breast

HER2-negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡